Top VC Firms in China
The 25 highest-scoring venture funds headquartered in China, ranked from 53 eligible firms on a 110-point composite of portfolio outcomes, deal volume, risk adjustment and cheque-size fit.
INCE Capital focuses on investments in China. They primarily invest in consumer, lifestyle, and services companies at the U stage.
Investments
17
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Linear Capital invests in earliest-stage startups applying frontier technologies, focusing on AI software and applications, AI hardware and embodied intelligence, AI for science and manufacturing, energy materials, and biotech, primarily in China.
Investments
65
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Focuses on early-stage investments in China. Primarily invests in the consumer, lifestyle, and services sectors, targeting B2C companies.
Investments
66
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Founded in 2017, Quan Capital is a venture capital firm based in Shanghai, China. The firm prefers to invest in the therapeutic biotech/pharma, enabling technologies/high-end specialty services, and companion diagnostic & precision medicine sectors.
Investments
32
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Investments
14
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Volcanic Ventures
Focuses on Series B investments in China. Primarily invests in the Industry & Hardware sector, supporting B2B companies.
Investments
30
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Trustbridge Partners is a growth equity firm focusing on investments in the consumer, healthcare, and technology sectors in China.
Investments
14
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Alibaba Group is a large conglomerate that invests across various sectors, primarily focusing on companies that can benefit from or integrate with its existing e-commerce ecosystem. They target growth-stage companies in sectors like e-commerce, logistics, digital media, and technology, with a strong interest in the Chinese and Indian markets.
Investments
79
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Founded in 2011, Shunwei Capital is a venture capital firm based in Beijing, China. The firm seeks to invest in deep technology, smart manufacturing, Internet+, consumption, enterprise services, and the electric-vehicle sectors.
Investments
71
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Enlight Growth Partners is a China-focused growth capital investor. They target opportunities in supply chain, data, fintech, SaaS and IoT.
Investments
42
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Primavera Capital Group is an Asia Pacific-based global investment firm connecting global investors with leading companies in the Asia Pacific region. The firm seeks to develop trusted, lasting partnerships with high-potential growth companies to promote entrepreneurship, fuel innovation, create business value, and have a positive impact on the world.
Investments
34
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Focuses on investments in Chinese companies. Primarily invests in the Healthcare & Life Sciences sector, with a preference for later-stage ventures.
Investments
18
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Boyu Capital focuses on late-stage investments primarily in China, with a key emphasis on healthcare, biotech, technology, and consumer internet sectors. They back growth-stage startups positioned to scale rapidly in these high-potential markets.
Investments
23
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
CITIC Capital is a global alternative investment management and advisory company that invests primarily in private equity, real estate, structured investment and finance, special situations, and asset management, focusing on China-related investments.
Investments
21
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Legend Capital invests primarily in growth-stage companies in China, focusing on biotechnology, healthcare, and emerging technologies. They target innovation-driven startups at series-a to series-c-plus stages to support scalable enterprises in B2B and B2C markets.
Investments
21
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
ZhenFund focuses on early to growth-stage investments primarily in China, investing in technology, healthcare, and AI sectors. The firm supports startups across B2B, B2C, and B2B2C models, aiming to back visionary entrepreneurs with scalable business potential.
Investments
94
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
5Y Capital (formerly known as Morningside Ventures) is a venture capital firm that invests in early to growth-stage companies across various sectors, including healthcare, consumer, and technology.
Investments
47
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Invests in late-stage companies in China. Focuses on the Healthcare & Life Sciences sector.
Investments
35
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Baidu Ventures (BV) is an independent venture capital firm focusing on artificial intelligence (AI) and deep technology. They invest in early-stage companies with innovative technologies and high growth potential.
Investments
26
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Focuses on investments in the consumer, lifestyle, and services sectors, primarily in China. They typically invest in companies at the Series F stage.
Investments
74
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Focuses on early and growth-stage investments in the healthcare and life sciences sectors across Asia. They target companies with innovative technologies and strong growth potential.
Investments
38
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Focuses on early-stage investments in the US. Specializes in the Industry & Hardware sector.
Investments
23
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Sinovation Ventures invests primarily in early and growth-stage AI and technology startups focused on China and global markets, emphasizing innovation in education, healthcare, and frontier technologies to empower the future of artificial intelligence.
Investments
15
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Focuses on investments in the Industry & Hardware sector, primarily in China. Targets companies in the Series C stage.
Investments
106
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Morningside focuses on partnering with innovative companies in technology and healthcare sectors primarily across China and North America, investing in growth-stage rounds to scale global market leaders.
Investments
16
Portfolio Size
—
Exit Rate
—
Alive
—
Portfolio Status
Not enough tracked outcomes yet
Portfolio Liveness
No alive portfolio to assess
Score Breakdown
Methodology
What the score measures, who is eligible, and what it deliberately excludes.
- How is the Brouky score for China calculated?
- Each firm is scored out of 110 points across four measured components: portfolio outcomes (40), deal volume (30), risk adjustment (25) and cheque-size fit (15). The score is computed from tracked investments and portfolio company status. It is not editorial and firms cannot influence it.
- Which firms are eligible for the China ranking?
- Venture and corporate venture funds headquartered in China with at least 5 tracked investments. 53 firms qualify; the top 25 are listed. Angel investors, family offices, banks, accelerators and government vehicles are excluded because they are scored on a different basis and are not comparable.
- How often is the ranking updated?
- Scores are recomputed as new investments and portfolio outcomes are recorded, and this page refreshes daily.
- My fund's data looks wrong. Can it be corrected?
- Yes. Claim the fund's profile on Brouky to review the underlying investments and portfolio records, and the score updates from the corrected data.